Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne Schimpl

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 24, 2019
Correction: Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapiesNicola L Lawson, Carly I Dix, Paul W Scorer, et al.
Nature Chemical Biology|October 30, 2012
O-GlcNAc transferase invokes nucleotide sugar pyrophosphate participation in catalysisMarianne Schimpl, Xiaowei Zheng, Vladimir S Borodkin, et al.
Chemical Science|June 30, 2023
Combining structural and coevolution information to unveil allosteric sitesGiuseppina La Sala, Christopher Pfleger, Helena Käck, et al.
Nucleic Acids Research|December 29, 2025
Genetic evidence for PARP1 trapping as a driver of PARP inhibitor efficacy in BRCA mutant cancer cellsJonathan Ribeiro, Kjetil Hansen, Lotte van Beek, et al.
Open Biology|November 28, 2019
Loss of CRMP2 O-GlcNAcylation leads to reduced novel object recognition performance in miceVillo Muha, Ritchie Williamson, Rachel Hills, et al.
Journal of the American Chemical Society|May 16, 2020
Alkynyl Benzoxazines and Dihydroquinazolines as Cysteine Targeting Covalent Warheads and Their Application in Identification of Selective Irreversible Kinase InhibitorsKirsten McAulay, Emily A Hoyt, Morgan Thomas, et al.
ACS Medicinal Chemistry Letters|June 18, 2025
Discovery of Pyrimidoindolones as Novel Family VIII Bromodomain BindersJeffrey A Boerth, Marianne Schimpl, Simon C C Lucas, et al.
Journal of Medicinal Chemistry|December 19, 2019
The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-<i>a</i>]pyridin-6-yl)amino]-9-(tetrahydro-2<i>H</i>-pyran-4-yl)-7,9-dihydro-8<i>H</i>-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) InhibitorFrederick W Goldberg, M Raymond V Finlay, Attilla K T Ting, et al.
ACS Medicinal Chemistry Letters|August 18, 2022
Optimization of hERG and Pharmacokinetic Properties for Basic Dihydro-8<i>H</i>-purin-8-one Inhibitors of DNA-PKFrederick W Goldberg, Attilla K T Ting, David Beattie, et al.
Journal of Medicinal Chemistry|April 26, 2021
Fragment-Based Design of a Potent MAT2a Inhibitor and <i>in Vivo</i> Evaluation in an MTAP Null Xenograft ModelClaudia De Fusco, Marianne Schimpl, Ulf Börjesson, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 24, 2019
Correction: Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapiesNicola L Lawson, Carly I Dix, Paul W Scorer, et al.
Nature Chemical Biology|October 30, 2012
O-GlcNAc transferase invokes nucleotide sugar pyrophosphate participation in catalysisMarianne Schimpl, Xiaowei Zheng, Vladimir S Borodkin, et al.
Chemical Science|June 30, 2023
Combining structural and coevolution information to unveil allosteric sitesGiuseppina La Sala, Christopher Pfleger, Helena Käck, et al.
Nucleic Acids Research|December 29, 2025
Genetic evidence for PARP1 trapping as a driver of PARP inhibitor efficacy in BRCA mutant cancer cellsJonathan Ribeiro, Kjetil Hansen, Lotte van Beek, et al.
Open Biology|November 28, 2019
Loss of CRMP2 O-GlcNAcylation leads to reduced novel object recognition performance in miceVillo Muha, Ritchie Williamson, Rachel Hills, et al.
Journal of the American Chemical Society|May 16, 2020
Alkynyl Benzoxazines and Dihydroquinazolines as Cysteine Targeting Covalent Warheads and Their Application in Identification of Selective Irreversible Kinase InhibitorsKirsten McAulay, Emily A Hoyt, Morgan Thomas, et al.
ACS Medicinal Chemistry Letters|June 18, 2025
Discovery of Pyrimidoindolones as Novel Family VIII Bromodomain BindersJeffrey A Boerth, Marianne Schimpl, Simon C C Lucas, et al.
Journal of Medicinal Chemistry|December 19, 2019
The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-<i>a</i>]pyridin-6-yl)amino]-9-(tetrahydro-2<i>H</i>-pyran-4-yl)-7,9-dihydro-8<i>H</i>-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) InhibitorFrederick W Goldberg, M Raymond V Finlay, Attilla K T Ting, et al.
ACS Medicinal Chemistry Letters|August 18, 2022
Optimization of hERG and Pharmacokinetic Properties for Basic Dihydro-8<i>H</i>-purin-8-one Inhibitors of DNA-PKFrederick W Goldberg, Attilla K T Ting, David Beattie, et al.
Journal of Medicinal Chemistry|April 26, 2021
Fragment-Based Design of a Potent MAT2a Inhibitor and <i>in Vivo</i> Evaluation in an MTAP Null Xenograft ModelClaudia De Fusco, Marianne Schimpl, Ulf Börjesson, et al.
Pageof 5